ALS is a heterogeneous disease. While 10-15% of cases are linked to inherited mutations, nearly 85% are sporadic.

PRISM ALS is a new global initiative designed to accelerate the discovery of effective treatments for ALS/MND by improving ...

A new global initiative launched today aims to close a critical gap in ALS/MND drug discovery - current cell models used for ...

Institut für Psychiatrie. Researchers showed that the level ...

Schizophrenia is a severe mental disorder affecting about 1% of the population worldwide, and is notoriously difficult to ...

Development of patient-specific human organoids models for heart, liver, and kidney tissues ...

Researchers at Washington University School of Medicine in St. Louis have shown that a small chemical compound can restore ...

To model tumor biology, Emulate’s platform introduces stromal contents by tuning the extracellular matrix stiffness and composition, as well as recreating essential gradients. The method captures ...

As Hong Kong deepens its integration into the Greater Bay Area, English proficiency matters even more: it helps Hong Kong ...

The Icahn School of Medicine at Mount Sinai has successfully harnessed AI to advance Alzheimer's Disease research.

GERMANTOWN, MD / ACCESS Newswire / March 30, 2026 / uBriGene Biosciences, a leading global CDMO specializing in lentiviral vector manufacturing and Advanced Therapy Medicinal Product (ATMP) developmen ...

XCells Biotechnologies, a provider of human cell-based solutions and custom iPSC services, has entered an international ...